
What is Wegovy and who is it for?
Wegovy (semaglutide) is a prescription medicine made by Novo Nordisk. Used with a reduced-calorie diet and more physical activity, it is FDA-approved to:
Help you lose weight and keep it off: in adults with obesity, or with overweight and at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol.
Protect your heart: reduce the risk of major cardiovascular events, such as heart attack and stroke, in adults with established cardiovascular disease and either obesity or overweight.
Treat a liver condition: the injection is also approved for adults with MASH (metabolic dysfunction-associated steatohepatitis) with moderate to advanced liver scarring but no cirrhosis. This use has accelerated approval.
Wegovy also comes as a once-daily pill for weight and heart protection. Read about the Wegovy pill.

What results looked like in the main trial
In STEP 1, a 68-week trial of 1,961 adults with obesity, or overweight and a weight-related condition, who did not have diabetes, people taking Wegovy 2.4 mg each week lost an average of 14.9% of their body weight. People taking a placebo lost 2.4%. Everyone also had lifestyle support.
About half of the people on Wegovy (50.5%) lost 15% or more of their body weight, compared with 4.9% on placebo. Nausea and diarrhea were the most common side effects, and they were usually mild to moderate and eased with time.
Your results will be your own. A trial average is not a promise, and what you build alongside the medicine, protein, strength work and sleep, helps decide whether the weight stays off.
Source: Wilding JPH and colleagues, New England Journal of Medicine, 2021 (STEP 1).

How Wegovy works
Semaglutide acts like GLP-1, a hormone your gut releases after you eat. It works on the biology that pushes back when you try to lose weight.
Quiets hunger: it tells your brain you have had enough, so smaller portions feel like enough.
Keeps you full longer: food leaves your stomach more slowly, so you stay satisfied between meals.
Steadies blood sugar: it helps your body release insulin when blood sugar rises.
Taking it safely
Wegovy is a once-weekly injection under the skin of your stomach area, thigh or upper arm, on the same day each week, at any time of day, with or without food. Your physician starts you on a low dose and raises it every 4 weeks so your body can adjust, and your care team shows you how to inject.
Most side effects are stomach-related and ease as your body adjusts. Wegovy is not right for everyone, so your physician goes through your health history with you first. The details from the FDA label are below.
Dosing steps
- The label's schedule raises the dose every 4 weeks:
- 0.25 mg each week for weeks 1 to 4, then 0.5 mg for weeks 5 to 8.
- 1 mg for weeks 9 to 12, then 1.7 mg for weeks 13 to 16.
- The usual maintenance dose is 2.4 mg each week, with 1.7 mg as an option. For weight in adults, your physician may raise it to 7.2 mg if you need it and tolerate it.
Common side effects
- The most common side effects are stomach-related: nausea, diarrhea, vomiting, constipation and stomach pain. Headache, tiredness, indigestion, dizziness and hair loss can also happen.
- They are most likely when you start or raise the dose, and they often ease as your body adjusts.
- Your care team can help with what to eat, portion size and dose timing while your body gets used to it.
Boxed warning
- In studies in rodents, semaglutide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid cancer, in people.
- Tell your physician right away about a lump or swelling in your neck, trouble swallowing, shortness of breath or hoarseness that does not go away.
Who should not take it
- Semaglutide is not for you if you or a family member has had medullary thyroid cancer (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2).
- It is also not for anyone who has had a serious allergic reaction to semaglutide or to anything in the medicine.
- Do not take it with another semaglutide or GLP-1 medicine.
- If you are pregnant or planning a pregnancy, tell your physician. The Wegovy label advises stopping at least 2 months before a planned pregnancy.
Less common but serious
- Less common but serious problems listed on the label include inflammation of the pancreas (stomach pain that is severe and does not go away), gallbladder problems, and kidney problems from losing fluid through vomiting or diarrhea.
- Others are severe stomach problems, serious allergic reactions, low blood sugar (mostly with insulin or a sulfonylurea), a faster heart rate, and eye changes in people with type 2 diabetes.
- Tell your care team before any surgery or sedation: GLP-1 medicines can raise the risk of food getting into the lungs during anesthesia.
What Wegovy costs
With insurance: coverage depends on your plan. We check it before your first visit, submit the prior authorization for you and handle appeals if needed. Read how to check your GLP-1 coverage.
Savings cards: as of November 2026, maker savings cards for commercial insurance can bring the cost to as little as $25 a month, with savings caps, and are not available to people with government coverage. We help you apply.
Paying cash: as of November 2026, NovoCare's self-pay price for the Wegovy pen is $199 a month for a new patient's first two fills of 0.25 mg and 0.5 mg through December 31, 2026, then $349. Wegovy 7.2 mg is $399. TrumpRx lists the Wegovy pen from $199 a month. You pay the maker's pharmacy, not Aayu Well, and the maker may change its prices. You can compare cash prices.
Medicare: we bill Medicare for visits, and we prescribe through the Medicare GLP-1 Bridge for people who qualify: $50 a month, July 1, 2026 to December 31, 2027. Read how the Medicare GLP-1 Bridge works.
Your visits: Most major insurance accepted, plus convenient cash pay options. Visits are billed to your insurance, and you pay any copay.
Coverage rules are changing. Read what changes for coverage in 2027.
How Aayu Well helps
Insurance checked first: we look at your coverage before your first visit, so you know your options before you decide.
Prior authorization handled: our team prepares and submits it for brand-name medicine as a concierge service, and handles appeals if your plan says no. Read what to do if Wegovy was denied.
Copay help: if you have commercial insurance, we help you use the maker's copay assistance.
A physician who knows you: Darshan Patel, MD, an obesity medicine physician, sees you by video or in person in Deer Park, Illinois, and adjusts your dose with you.
A registered dietitian: help with meals that fit your new appetite, protein on a GLP-1 and keeping your muscle.
A care team between visits: message us about side effects, doses or refills, and hear back from people who know your plan.
A plan for the long run: Do I have to take a GLP-1 forever?
We see patients in California, Georgia, Illinois, Indiana, Michigan, Ohio and Wisconsin.














